Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

    Stock Recap
    #PipelineProspector

    Menu

    Androcur

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,191Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/08/2025 Bayer AG
    Germany
    		 BAYER AG Leverkusen DE R1-CEP 1999-102 - Rev 04 Cyproterone acetate, Variant 1 2017-03-03 Valid Chemical 1094
    28/08/2025 Bayer AG
    Germany
    		 BAYER AG Leverkusen DE R1-CEP 2005-168 - Rev 01 Cyproterone acetate 2017-03-03 Valid Chemical 1094